Banner - NPPA Connect

|Videos|April 7, 2023

Expert Perspectives on the Role of Interdisciplinary Care in BCC

Author(s)Laura Ferris, MD, PhD, Andrew Weinstein, MD, FAAD

Laura Ferris, MD, PhD and Andrew Weinstein, MD, FAAD discuss the importance of multidisciplinary care in their patients with locally advanced basal cell carcinoma, reinforcing the role of the dermatologist in the care plan.

Episodes in this series

EP. 1 Basal Cell Carcinoma Management Challenges

EP. 1 Basal Cell Carcinoma Management Challenges

EP. 2 Role of Multidisciplinary Care and Early BCC Identification

EP. 2 Role of Multidisciplinary Care and Early BCC Identification

EP. 3 Expert Perspectives on the Role of Interdisciplinary Care in BCC

EP. 3 Expert Perspectives on the Role of Interdisciplinary Care in BCC

EP. 4 Considerations in Treatment Selection for BCC

EP. 4 Considerations in Treatment Selection for BCC

EP. 5 Expert Perspectives in BCC Management

EP. 5 Expert Perspectives in BCC Management

EP. 6 Advances in Locally Advanced BCC Management

EP. 6 Advances in Locally Advanced BCC Management

EP. 7 Clinical Utilization of Cemiplimab and Future Directions

EP. 7 Clinical Utilization of Cemiplimab and Future Directions

EP. 8 Frontline Forum Part 1: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 8 Frontline Forum Part 1: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 9 Frontline Forum Part 2: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 9 Frontline Forum Part 2: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 10 Frontline Forum Part 3: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 10 Frontline Forum Part 3: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 11 Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 11 Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 12 Addressing the Challenges and Options to Treat Basal Cell Carcinoma

EP. 12 Addressing the Challenges and Options to Treat Basal Cell Carcinoma

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

TNF Inhibitors Linked to Increased Skin Cancer Risk in Long-Term Cohort Study

ByShannon Heaning, Content Associate

July 22nd 2026

New Frontiers in CSCC: Experts Weigh Immunotherapy Options and Collaborative Referral Pathways

ByMarie Bosslett, Assistant Editor

July 17th 2026

Medicus Pharma Targets Gorlin Syndrome and BCC Backlog with Novel Immuno-Oncology Patch

ByRaza Bokhari, MD,Marie Bosslett, Assistant Editor

June 17th 2026

Raza Bokhari, MD: How SkinJect is Changing Nonmelanoma Skin Cancer Care

ByRaza Bokhari, MD,Marie Bosslett, Assistant Editor

June 16th 2026

The Expanding Role of Immunotherapies for Non-Melanoma Skin Cancers

ByJoshua Burshtein, MD,Todd Schlesinger, MD, FAAD, FASMS

June 15th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Oral Collagen Improves Skin Hydration and Elasticity, but Benefits for Wrinkles Remain Unproven

National Psoriasis Awareness Month 2026: More Oral Options, Wider Access, and a Systemic Lens

Rezpegaldesleukin Improves Atopic Dermatitis in Phase 2b Trial

Comparing Safety, Tolerability, and Clinical Fit of Advanced cSCC Immunotherapies

The Multibillion-Dollar Molecule: How Zumilokibart’s Phase 2 Success Sparked AbbVie’s Acquisition